Biomedical Catalyst 2021 Round 2: Feasibility & Primer Awards

Key Features

UK registered businesses can apply for a share of up to £12 million to develop innovative healthcare products, technologies and processes.

Programme:     Innovate UK

Award:     Share of up to £12 million

Opens: 18th Oct 2021

Closes: 1st Dec 2021

! This scheme is now closed

Innovate UK, part of UK Research and Innovation, will invest up to £12 million for businesses to develop innovative healthcare products, technologies and processes.


The aim of this competition is to explore and evaluate the commercial potential of an innovative scientific idea or carry out a technical evaluation through to proof of concept in a model system. Your project must focus on the development of a product or process that is an innovative solution to a health and care challenge

This competition combines the feasibility and primer strands of the Biomedical Catalyst.

Your project can:

  • review research evidence and identify possible applications
  • assess business opportunities
  • assess or protect intellectual property
  • validate initial concepts and existing pre-clinical work through experimental studies
  • initially demonstrate using in-vitro and in-vivo models, but not human clinical trials
  • develop early-stage prototyping
  • acquire preliminary regulatory advice

Your project can focus on any health and care sector or discipline.

Innovate UK particularly welcomes applications that support innovation in the following areas:

  • child health technologies
  • innovations that support clinical trials in the UK
  • biomedical innovations that combat the threat of antimicrobial resistance

Your project can align with one or more of the following:

  • medical technologies and devices
  • stratified healthcare
  • advanced therapies such as gene and cell therapies
  • digital health
  • drug discovery
  • diagnostics


Your project must:

  • have total eligible costs between £50,000 and £1million
  • start on 1 April 2022
  • end by 31 March 2024
  • last between 3 months and 24 months
  • carry out all of its project work in the UK
  • intend to exploit the results from or in the UK

To lead a project or work alone your organisation must be a UK registered micro, small or medium-sized enterprise (SME)

Academic institutions cannot lead or work alone.

Subcontractors are allowed in this competition.

You can use a previously submitted application to apply for this competition.


Innovate UK are not funding projects that are:

  • in scope for the Biomedical Catalyst early-stage or late-stage awards
  • not related to human life sciences
  • already on the market
  • laboratory accreditation
  • conducted to anything less than the highest standards of animal welfare
  • dependent on export performance – for example giving a subsidy to a baker on the condition that it exports a certain quantity of bread to another country
  • dependent on domestic inputs usage- for example giving a subsidy to a baker on the condition that it uses 50% UK flour in their product
  • failed to exploit a previously funded project
  • an overdue independent accountant’s report
  • failed to comply with grant terms and conditions

Funding Costs

Innovate UK have allocated up to £12 million to fund innovation projects in this competition.

If the majority of your organisation’s work on the project is commercial or economic, your funding request must not exceed the limits below. These limits apply even if your organisation normally acts non-economically.

For feasibility studies and industrial research projects, you could get funding for your eligible project costs of:

  • up to 70% if you are a micro or small organisation
  • up to 60% if you are a medium-sized organisation



Get in touch

How can we help?(Required)
Send Enquiry